The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers

1.

Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57–70. https://doi.org/10.1016/s0092-8674(00)81683-9CrossRefPubMed

2.

Vasudev, N. S., & Reynolds, A. R. (2014). Anti-angiogenic therapy for cancer: Current progress, unresolved questions and future directions. [; Research Support, Non-U.S. Gov’t Review]. Angiogenesis, 17(3), 471–494. https://doi.org/10.1007/s10456-014-9420-yCrossRefPubMedPubMedCentral

3.

Jayson, G. C., Kerbel, R., Ellis, L. M., & Harris, A. L. (2016). Antiangiogenic therapy in oncology: Current status and future directions. Lancet, 388(10043), 518–529. https://doi.org/10.1016/s0140-6736(15)01088-0CrossRefPubMed

4.

Cloughesy, T. F., Brenner, A., de Groot, J. F., Butowski, N. A., Zach, L., Campian, J. L., et al. (2020). A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE). Neuro-Oncology, 22(5), 705–717. https://doi.org/10.1093/neuonc/noz232CrossRefPubMed

5.

Zeng, Y., & Fu, B. M. (2020). Resistance mechanisms of anti-angiogenic therapy and exosomes-mediated revascularization in cancer. Frontiers in Cell and Developmental Biology, 8, 610661. https://doi.org/10.3389/fcell.2020.610661CrossRefPubMedPubMedCentral

6.

Kuczynski, E. A., Vermeulen, P. B., Pezzella, F., Kerbel, R. S., & Reynolds, A. R. (2019). Vessel co-option in cancer. Nature Reviews Clinical Oncology, 16(8), 469–493. https://doi.org/10.1038/s41571-019-0181-9CrossRefPubMed

7.

Zhang, J., Qiao, L., Liang, N., Xie, J., Luo, H., Deng, G., et al. (2016). Vasculogenic mimicry and tumor metastasis. Journal of B.U.ON., 21(3), 533–541.PubMed

8.

Latacz, E., Caspani, E., Barnhill, R., Lugassy, C., Verhoef, C., Grunhagen, D., et al. (2020). Pathological features of vessel co-option versus sprouting angiogenesis. Angiogenesis, 23(1), 43–54. https://doi.org/10.1007/s10456-019-09690-0CrossRefPubMed

9.

Kuczynski, E. A., & Reynolds, A. R. (2020). Vessel co-option and resistance to anti-angiogenic therapy. Angiogenesis, 23(1), 55–74. https://doi.org/10.1007/s10456-019-09698-6CrossRefPubMed

10.

Fathi Maroufi, N., Taefehshokr, S., Rashidi, M.-R., Taefehshokr, N., Khoshakhlagh, M., Isazadeh, A., et al. (2020). Vascular mimicry: Changing the therapeutic paradigms in cancer. Molecular Biology Reports, 47(6), 4749–4765. https://doi.org/10.1007/s11033-020-05515-2CrossRefPubMed

11.

Kristensen, L. S., Andersen, M. S., Stagsted, L. V. W., Ebbesen, K. K., Hansen, T. B., & Kjems, J. (2019). The biogenesis, biology and characterization of circular RNAs. Nature Reviews Genetics, 20(11), 675–691. https://doi.org/10.1038/s41576-019-0158-7CrossRefPubMed

12.

Shao, Y., Lu, B. (2020). The crosstalk between circular RNAs and the tumor microenvironment in cancer metastasis. Cancer Cell International, 20(1), https://doi.org/10.1186/s12935-020-01532-0

13.

Pezzella, F., Di Bacco, A., Andreola, S., Nicholson, A. G., Pastorino, U., & Harris, A. L. (1996). Angiogenesis in primary lung cancer and lung secondaries. The European Journal of Cancer, 32a(14), 2494–2500. https://doi.org/10.1016/s0959-8049(96)00377-2CrossRefPubMed

14.

Pezzella, F., Pastorino, U., Tagliabue, E., Andreola, S., Sozzi, G., Gasparini, G., et al. (1997). Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. American Journal of Pathology, 151(5), 1417–1423.PubMedPubMedCentral

15.

Lugassy, C., Zadran, S., Bentolila, L. A., Wadehra, M., Prakash, R., Carmichael, S. T., et al. (2014). Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: An alternative to intravascular cancer dissemination. Cancer Microenvironment, 7(3), 139–152. https://doi.org/10.1007/s12307-014-0156-4CrossRefPubMedPubMedCentral

16.

Baker, G. J., Yadav, V. N., Motsch, S., Koschmann, C., Calinescu, A. A., Mineharu, Y., et al. (2014). Mechanisms of glioma formation: Iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia, 16(7), 543–561. https://doi.org/10.1016/j.neo.2014.06.003CrossRefPubMedPubMedCentral

17.

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia (2009). Hepatology, 49(2), 658–664, https://doi.org/10.1002/hep.22709

18.

van Dam, P. J., van der Stok, E. P., Teuwen, L. A., Van den Eynden, G. G., Illemann, M., Frentzas, S., et al. (2017). International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. British Journal of Cancer, 117(10), 1427–1441. https://doi.org/10.1038/bjc.2017.334CrossRefPubMedPubMedCentral

19.

Rada, M., Lazaris, A., Kapelanski-Lamoureux, A., Mayer, T. Z., & Metrakos, P. (2020). Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: A theoretical model. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2020.09.001CrossRefPubMed

20.

Griveau, A., Seano, G., Shelton, S. J., Kupp, R., Jahangiri, A., Obernier, K., et al. (2018). A glial signature and wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment. Cancer Cell, 33(5), 874-889.e877. https://doi.org/10.1016/j.ccell.2018.03.020CrossRefPubMedPubMedCentral

21.

Kuczynski, E. A., Yin, M., Bar-Zion, A., Lee, C. R., Butz, H., Man, S., et al. (2016). Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma. Journal of the National Cancer Institute, 108(8), https://doi.org/10.1093/jnci/djw030

22.

Voutouri, C., Kirkpatrick, N. D., Chung, E., Mpekris, F., Baish, J. W., Munn, L. L., et al. (2019). Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies. Proceedings of the National Academy of Sciences of the United States of America, 116(7), 2662–2671. https://doi.org/10.1073/pnas.1818322116CrossRefPubMedPubMedCentral

23.

Bridgeman, V. L., Vermeulen, P. B., Foo, S., Bilecz, A., Daley, F., Kostaras, E., et al. (2017). Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. Journal of Pathology, 241(3), 362–374. https://doi.org/10.1002/path.4845CrossRefPubMed

24.

Dome, B., Timar, J., & Paku, S. (2003). A novel concept of glomeruloid body formation in experimental cerebral metastases. Journal of Neuropathology and Experimental Neurology, 62(6), 655–661.CrossRefPubMed

25.

Stessels, F., Van den Eynden, G., Van der Auwera, I., Salgado, R., Van den Heuvel, E., Harris, A. L., et al. (2004). Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. British Journal of Cancer, 90(7), 1429–1436. https://doi.org/10.1038/sj.bjc.6601727CrossRefPubMedPubMedCentral

26.

Vermeulen, P. B., Colpaert, C., Salgado, R., Royers, R., Hellemans, H., Van den Heuvel, E., et al. (2001). Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. Journal of Pathology, 195(3), 336–342. https://doi.org/10.1002/path.966CrossRefPubMed

27.

Kita, K., Itoshima, T., & Tsuji, T. (1991). Observation of microvascular casts of human hepatocellular-carcinoma by scanning electron-microscopy. Gastroenterologia Japonica, 26(3), 319–328.CrossRefPubMed

28.

Ebos, J. M., & Kerbel, R. S. (2011). Antiangiogenic therapy: Impact on invasion, disease progression, and metastasis. Nature Reviews. Clinical Oncology, 8(4), 210–221. https://doi.org/10.1038/nrclinonc.2011.21CrossRefPubMedPubMedCentral

29.

Roviello, G., Bachelot, T., Hudis, C. A., Curigliano, G., Reynolds, A. R., Petrioli, R., et al. (2017). The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials. European Journal of Cancer, 75, 245–258. https://doi.org/10.1016/j.ejca.2017.01.026CrossRefPubMed

30.

Porta, C., Cosmai, L., Leibovich, B. C., Powles, T., Gallieni, M., & Bex, A. (2019). The adjuvant treatment of kidney cancer: A multidisciplinary outlook. Nature reviews. Nephrology, 15(7), 423–433. https://doi.org/10.1038/s41581-019-0131-xCrossRefPubMed

31.

Frentzas, S., Simoneau, E., Bridgeman, V. L., Vermeulen, P. B., Foo, S., Kostaras, E., et al. (2016). Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nature Medicine, 22(11), 1294–1302. https://doi.org/10.1038/nm.4197CrossRefPubMedPubMedCentral

32.

Kölsch, V., Charest, P. G., & Firtel, R. A. (2008). The regulation of cell motility and chemotaxis by phospholipid signaling. Journal of Cell Science, 121(Pt 5), 551–559. https://doi.org/10.1242/jcs.023333CrossRefPubMed

33.

Lugassy, C., & Barnhill, R. L. (2007). Angiotropic melanoma and extravascular migratory metastasis: A review. Advances in Anatomic Pathology, 14(3), 195–201. https://doi.org/10.1097/PAP.0b013e31805048d9CrossRefPubMed

34.

Watkins, S., Robel, S., Kimbrough, I. F., Robert, S. M., Ellis-Davies, G., & Sontheimer, H. (2014). Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nature Communications, 5, 4196. https://doi.org/10.1038/ncomms5196CrossRefPubMed

35.

Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E., Goldbrunner, R., Herms, J., et al. (2010). Real-time imaging reveals the single steps of brain metastasis formation. Nature Medicine, 16(1), 116–122. https://doi.org/10.1038/nm.2072CrossRefPubMed

36.

Garcia-Gomez, P., & Valiente, M. (2020). Vascular co-option in brain metastasis. Angiogenesis, 23(1), 3–8. https://doi.org/10.1007/s10456-019-09693-xCrossRefPubMed

37.

Caspani, E. M., Crossley, P. H., Redondo-Garcia, C., & Martinez, S. (2014). Glioblastoma: A pathogenic crosstalk between tumor cells and pericytes. PLoS ONE, 9(7), e101402. https://doi.org/10.1371/journal.pone.0101402CrossRefPubMedPubMedCentral

38.

Tse, J. M., Cheng, G., Tyrrell, J. A., Wilcox-Adelman, S. A., Boucher, Y., Jain, R. K., et al. (2012). Mechanical compression drives cancer cells toward invasive phenotype. Proceedings of the National Academy of Sciences of the United States of America, 109(3), 911–916. https://doi.org/10.1073/pnas.1118910109CrossRefPubMed

39.

Butler, J. M., Kobayashi, H., & Rafii, S. (2010). Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nature Reviews Cancer, 10(2), 138–146. https://doi.org/10.1038/nrc2791CrossRefPubMedPubMedCentral

40.

Sharma, I., Singh, A., Siraj, F., & Saxena, S. (2018). IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma. Journal of Biomedical Science, 25(1), 62. https://doi.org/10.1186/s12929-018-0464-yCrossRefPubMedPubMedCentral

41.

Seano, G., & Jain, R. K. (2020). Vessel co-option in glioblastoma: Emerging insights and opportunities. Angiogenesis, 23(1), 9–16. https://doi.org/10.1007/s10456-019-09691-zCrossRefPubMed

42.

Pham, K., Luo, D., Siemann, D. W., Law, B. K., Reynolds, B. A., Hothi, P., et al. (2015). VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner. Cancer Letters, 360(1), 60–67. https://doi.org/10.1016/j.canlet.2015.02.005CrossRefPubMedPubMedCentral

43.

Donnem, T., Reynolds, A. R., Kuczynski, E. A., Gatter, K., Vermeulen, P. B., Kerbel, R. S., et al. (2018). Non-angiogenic tumours and their influence on cancer biology. Nature Reviews Cancer, 18(5), 323–336. https://doi.org/10.1038/nrc.2018.14CrossRefPubMed

44.

Palmieri, V., Lazaris, A., Mayer, T. Z., Petrillo, S. K., Alamri, H., Rada, M., et al. (2020). Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy. The Journal of Pathology, 251(2), 213–223. https://doi.org/10.1002/path.5449CrossRefPubMed

45.

Sun, D., Liu, J., & Zhou, L. (2019). Upregulation of circular RNA circ-FAM53B predicts adverse prognosis and accelerates the progression of ovarian cancer via the miR-646/VAMP2 and miR-647/MDM2 signaling pathways. Oncology Reports, 42(6), 2728–2737. https://doi.org/10.3892/or.2019.7366CrossRefPubMed

46.

Zhang, F., Xu, Y., Ye, W., Jiang, J., & Wu, C. (2020). Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2. Bioscience Reports, 40(7), https://doi.org/10.1042/BSR20200825

47.

Yanbin, Z., & Jing, Z. (2019). CircSAMD4A accelerates cell proliferation of osteosarcoma by sponging miR-1244 and regulating MDM2 mRNA expression. Biochemical and Biophysical Research Communications, 516(1), 102–111. https://doi.org/10.1016/j.bbrc.2019.05.182CrossRefPubMed

48.

Jin, Y., Li, L., Zhu, T., & Liu, G. (2019). Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma. Pathology - Research and Practice, 215(12), 152688. https://doi.org/10.1016/j.prp.2019.152688CrossRefPubMed

49.

Ma, W., Zhao, P., Zang, L., Zhang, K., Liao, H., & Hu, Z. (2020). CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p/MDM2 axis. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-020-01317-2CrossRefPubMed

50.

Liu, R., Zhou, M., Zhang, P., Zhao, Y., & Zhang, Y. (2020). Cell proliferation and invasion is promoted by circSERPINA3 in nasopharyngeal carcinoma by regulating miR-944/MDM2 axis. Journal of Cancer, 11(13), 3910–3918. https://doi.org/10.7150/jca.42799CrossRefPubMedPubMedCentral

51.

Wang, K., Sun, Y., Tao, W., Fei, X., & Chang, C. (2017). Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Letters, 394, 1–12. https://doi.org/10.1016/j.canlet.2016.12.036CrossRefPubMed

52.

Xing, L., Yang, R., Wang, X., Zheng, X., Yang, X., Zhang, L., et al. (2020). The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis. Aging (Albany NY), 12(11), 10983–11003. https://doi.org/10.18632/aging.103311CrossRef

53.

Hong, Y., Qin, H., Li, Y., Zhang, Y., Zhuang, X., Liu, L., et al. (2019). FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression. Journal of Cellular Physiology, 234(11), 19895–19910. https://doi.org/10.1002/jcp.28588CrossRefPubMedPubMedCentral

54.

Ma, H. B., Yao, Y. N., Yu, J. J., Chen, X. X., & Li, H. F. (2018). Extensive profiling of circular RNAs and the potential regulatory role of circRNA-000284 in cell proliferation and invasion of cervical cancer via sponging miR-506. American Journal of Translational Research, 10(2), 592–604.PubMedPubMedCentral

55.

Du, W. W., Yang, W., Li, X., Fang, L., Wu, N., Li, F., et al. (2020). The circular RNA circSKA3 binds integrin beta1 to induce invadopodium formation enhancing breast cancer invasion. Molecular Therapy, 28(5), 1287–1298. https://doi.org/10.1016/j.ymthe.2020.03.002CrossRefPubMedPubMedCentral

56.

Yang, W., & Xie, T. (2020). Hsa_circ_CSPP1/MiR-361-5p/ITGB1 regulates proliferation and migration of cervical cancer (CC) by modulating the PI3K-Akt signaling pathway. Reproductive Sciences, 27(1), 132–144. https://doi.org/10.1007/s43032-019-00008-5CrossRefPubMed

57.

Wang, N., Lu, K., Qu, H., Wang, H., Chen, Y., Shan, T., et al. (2020). CircRBM33 regulates IL-6 to promote gastric cancer progression through targeting miR-149. Biomedicine & Pharmacotherapy, 125, 109876. https://doi.org/10.1016/j.biopha.2020.109876CrossRef

58.

Xu, Z., Tie, X., Li, N., Yi, Z., Shen, F., & Zhang, Y. (2020). Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway. IUBMB Life, 72(3), 426–439. https://doi.org/10.1002/iub.2202CrossRefPubMed

59.

Zhang, P. F., Pei, X., Li, K. S., Jin, L. N., Wang, F., Wu, J., et al. (2019). Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Molecular Cancer, 18(1), 179. https://doi.org/10.1186/s12943-019-1111-2CrossRefPubMedPubMedCentral

60.

Li, H., Yao, G., Feng, B., Lu, X., & Fan, Y. (2018). Circ_0056618 and CXCR4 act as competing endogenous in gastric cancer by regulating miR-206. Journal of Cellular Biochemistry, 119(11), 9543–9551. https://doi.org/10.1002/jcb.27271CrossRefPubMed

61.

Zheng, X., Ma, Y. F., Zhang, X. R., Li, Y., Zhao, H. H., & Han, S. G. (2020). Circ_0056618 promoted cell proliferation, migration and angiogenesis through sponging with miR-206 and upregulating CXCR4 and VEGF-A in colorectal cancer. European Review for Medical and Pharmacological Sciences, 24(8), 4190–4202. https://doi.org/10.26355/eurrev_202004_20999CrossRefPubMed

62.

He, F., Zhong, X., Lin, Z., Lin, J., Qiu, M., Li, X., et al. (2020). Plasma exo-hsa_circRNA_0056616: A potential biomarker for lymph node metastasis in lung adenocarcinoma. Journal of Cancer, 11(14), 4037–4046. https://doi.org/10.7150/jca.30360CrossRefPubMedPubMedCentral

63.

Adighibe, O., & Pezzella, F. (2018). The Role of JMY in p53 Regulation. Cancers (Basel), 10(6), https://doi.org/10.3390/cancers10060173

64.

Coutts, A. S., Weston, L., & La Thangue, N. B. (2010). Actin nucleation by a transcription co-factor that links cytoskeletal events with the p53 response. Cell Cycle, 9(8), 1511–1515. https://doi.org/10.4161/cc.9.8.11258CrossRefPubMed

65.

Coutts, A. S., Boulahbel, H., Graham, A., & La Thangue, N. B. (2007). Mdm2 targets the p53 transcription cofactor JMY for degradation. EMBO Reports, 8(1), 84–90. https://doi.org/10.1038/sj.embor.7400855CrossRefPubMed

66.

Talme, T., Bergdahl, E., & Sundqvist, K. G. (2014). Regulation of T-lymphocyte motility, adhesion and de-adhesion by a cell surface mechanism directed by low density lipoprotein receptor-related protein 1 and endogenous thrombospondin-1. Immunology, 142(2), 176–192. https://doi.org/10.1111/imm.12229CrossRefPubMedPubMedCentral

67.

Daubon, T., Léon, C., Clarke, K., Andrique, L., Salabert, L., Darbo, E., et al. (2019). Deciphering the complex role of thrombospondin-1 in glioblastoma development. Nature Communications, 10(1), 1146. https://doi.org/10.1038/s41467-019-08480-yCrossRefPubMedPubMedCentral

68.

Skandalis, S. S., Karalis, T. T., Chatzopoulos, A., & Karamanos, N. K. (2019). Hyaluronan-CD44 axis orchestrates cancer stem cell functions. Cellular Signalling, 63, 109377. https://doi.org/10.1016/j.cellsig.2019.109377CrossRefPubMed

69.

Lazaris, A., Amri, A., Petrillo, S. K., Zoroquiain, P., Ibrahim, N., Salman, A., et al. (2018). Vascularization of colorectal carcinoma liver metastasis: Insight into stratification of patients for anti-angiogenic therapies. The Journal of Pathology: Clinical Research, 4(3), 184–192. https://doi.org/10.1002/cjp2.100CrossRefPubMedPubMedCentral

70.

Samatov, T. R., Wicklein, D., & Tonevitsky, A. G. (2016). L1CAM: Cell adhesion and more. Progress in Histochemistry and Cytochemistry, 51(2), 25–32. https://doi.org/10.1016/j.proghi.2016.05.001CrossRefPubMed

71.

Valiente, M., Obenauf, A. C., Jin, X., Chen, Q., Zhang, X. H., Lee, D. J., et al. (2014). Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell, 156(5), 1002–1016. https://doi.org/10.1016/j.cell.2014.01.040CrossRefPubMedPubMedCentral

72.

Er, E. E., Valiente, M., Ganesh, K., Zou, Y., Agrawal, S., Hu, J., et al. (2018). Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nature Cell Biology, 20(8), 966–978. https://doi.org/10.1038/s41556-018-0138-8CrossRefPubMedPubMedCentral

73.

Bugyik, E., Dezso, K., Reiniger, L., László, V., Tóvári, J., Tímár, J., et al. (2011). Lack of angiogenesis in experimental brain metastases. Journal of Neuropathology and Experimental Neurology, 70(11), 979–991. https://doi.org/10.1097/NEN.0b013e318233afd7CrossRefPubMed

74.

Yao, H., Price, T. T., Cantelli, G., Ngo, B., Warner, M. J., Olivere, L., et al. (2018). Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature, 560(7716), 55–60. https://doi.org/10.1038/s41586-018-0342-5CrossRefPubMed

75.

Carbonell, W. S., DeLay, M., Jahangiri, A., Park, C. C., & Aghi, M. K. (2013). β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma. Cancer Research, 73(10), 3145–3154. https://doi.org/10.1158/0008-5472.can-13-0011CrossRefPubMedPubMedCentral

76.

Chen, D. L., Zeng, Z. L., Yang, J., Ren, C., Wang, D. S., Wu, W. J., et al. (2013). L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer. Journal of Hematology & Oncology, 6, 43. https://doi.org/10.1186/1756-8722-6-43CrossRef

77.

Colombo, F., & Meldolesi, J. (2015). L1-CAM and N-CAM: From adhesion proteins to pharmacological targets. Trends in Pharmacological Sciences, 36(11), 769–781. https://doi.org/10.1016/j.tips.2015.08.004CrossRefPubMed

78.

Carbonell, W. S., Ansorge, O., Sibson, N., & Muschel, R. (2009). The vascular basement membrane as “soil” in brain metastasis. PLoS ONE, 4(6), e5857. https://doi.org/10.1371/journal.pone.0005857CrossRefPubMedPubMedCentral

79.

Eddy, R. J., Weidmann, M. D., Sharma, V. P., & Condeelis, J. S. (2017). Tumor Cell Invadopodia: Invasive Protrusions that Orchestrate Metastasis. Trends in Cell Biology, 27(8), 595–607. https://doi.org/10.1016/j.tcb.2017.03.003CrossRefPubMedPubMedCentral

80.

Lorenz, M., Yamaguchi, H., Wang, Y., Singer, R. H., & Condeelis, J. (2004). Imaging sites of N-wasp activity in lamellipodia and invadopodia of carcinoma cells. Current Biology, 14(8), 697–703. https://doi.org/10.1016/j.cub.2004.04.008CrossRefPubMed

81.

Marx, J. (2006). Cell biology. Podosomes and invadopodia help mobile cells step lively. Science, 312(5782), 1868–1869. https://doi.org/10.1126/science.312.5782.1868CrossRefPubMed

82.

Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016). Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biology, 37(9), 11553–11572. https://doi.org/10.1007/s13277-016-5098-7CrossRefPubMed

83.

Waugh, D. J., & Wilson, C. (2008). The interleukin-8 pathway in cancer. Clinical Cancer Research, 14(21), 6735–6741. https://doi.org/10.1158/1078-0432.ccr-07-4843CrossRefPubMed

84.

Auf, G., Jabouille, A., Guérit, S., Pineau, R., Delugin, M., Bouchecareilh, M., et al. (2010). Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proceedings of the National Academy of Sciences of the United States of America, 107(35), 15553–15558. https://doi.org/10.1073/pnas.0914072107CrossRefPubMedPubMedCentral

85.

Ron, D., & Walter, P. (2007). Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews Molecular Cell Biology, 8(7), 519–529. https://doi.org/10.1038/nrm2199CrossRefPubMed

86.

Donnem, T., Hu, J., Ferguson, M., Adighibe, O., Snell, C., Harris, A. L., et al. (2013). Vessel co-option in primary human tumors and metastases: An obstacle to effective anti-angiogenic treatment? Cancer Medicine, 2(4), 427–436. https://doi.org/10.1002/cam4.105CrossRefPubMedPubMedCentral

87.

Ohe, K., Tanaka, T., Horita, Y., Harada, Y., Yamasaki, T., Abe, I., et al. (2019). Circular IRE-type RNAs of the NR5A1 gene are formed in adrenocortical cells. Biochemical and Biophysical Research Communications, 512(1), 1–6. https://doi.org/10.1016/j.bbrc.2019.02.151CrossRefPubMed

88.

Ruf, W., Seftor, E. A., Petrovan, R. J., Weiss, R. M., Gruman, L. M., Margaryan, N. V., et al. (2003). Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Research, 63(17), 5381–5389.PubMed

89.

Wechman, S. L., Emdad, L., Sarkar, D., Das, S. K., & Fisher, P. B. (2020). Vascular mimicry: Triggers, molecular interactions and in vivo models. Advances in Cancer Research, 148, 27–67. https://doi.org/10.1016/bs.acr.2020.06.001.CrossRefPubMedPubMedCentral

90.

Ge, H., & Luo, H. (2018). Overview of advances in vasculogenic mimicry - A potential target for tumor therapy. Cancer Management and Research, 10, 2429–2437. https://doi.org/10.2147/cmar.s164675CrossRefPubMedPubMedCentral

91.

Karroum, A., Mirshahi, P., Benabbou, N., Faussat, A. M., Soria, J., Therwath, A., et al. (2010). Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways. Cancer Letters, 295(2), 242–251. https://doi.org/10.1016/j.canlet.2010.03.007CrossRefPubMed

92.

Lim, D., Do, Y., Kwon, B. S., Chang, W., Lee, M. S., Kim, J., et al. (2020). Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer. BMB Reports, 53(6), 291–298. https://doi.org/10.5483/BMBRep.2020.53.6.060CrossRefPubMedPubMedCentral

93.

Huang, B., Xiao, E., & Huang, M. (2015). MEK/ERK pathway is positively involved in hypoxia-induced vasculogenic mimicry formation in hepatocellular carcinoma which is regulated negatively by protein kinase A. Medical Oncology, 32(1), 408. https://doi.org/10.1007/s12032-014-0408-7CrossRefPubMed

94.

Williamson, S. C., Metcalf, R. L., Trapani, F., Mohan, S., Antonello, J., Abbott, B., et al. (2016). Vasculogenic mimicry in small cell lung cancer. Nature Communications, 7, 13322. https://doi.org/10.1038/ncomms13322CrossRefPubMedPubMedCentral

95.

Xu, Y., Li, Q., Li, X. Y., Yang, Q. Y., Xu, W. W., & Liu, G. L. (2012). Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis. Journal of Experimental & Clinical Cancer Research, 31(1), 16. https://doi.org/10.1186/1756-9966-31-16CrossRef

96.

Hu, Y. L., DeLay, M., Jahangiri, A., Molinaro, A. M., Rose, S. D., Carbonell, W. S., et al. (2012). Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Research, 72(7), 1773–1783. https://doi.org/10.1158/0008-5472.can-11-3831CrossRefPubMedPubMedCentral

97.

Angara, K., Borin, T. F., Rashid, M. H., Lebedyeva, I., Ara, R., Lin, P. C., et al. (2018). CXCR2-expressing tumor cells drive vascular mimicry in antiangiogenic therapy-resistant glioblastoma. Neoplasia, 20(10), 1070–1082. https://doi.org/10.1016/j.neo.2018.08.011CrossRefPubMedPubMedCentral

98.

Liu, R., Yang, K., Meng, C., Zhang, Z., & Xu, Y. (2012). Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. Cancer Biology & Therapy, 13(7), 527–533. https://doi.org/10.4161/cbt.19602CrossRef

99.

Valdivia, A., Mingo, G., Aldana, V., Pinto, M. P., Ramirez, M., Retamal, C., et al. (2019). Fact or fiction, it is time for a verdict on vasculogenic mimicry? Frontiers in Oncology, 9, 680. https://doi.org/10.3389/fonc.2019.00680CrossRefPubMedPubMedCentral

100.

Zhang, X., Zhang, J., Zhou, H., Fan, G., & Li, Q. (2019). Molecular mechanisms and anticancer therapeutic strategies in vasculogenic mimicry. Journal of Cancer, 10(25), 6327–6340. https://doi.org/10.7150/jca.34171CrossRefPubMedPubMedCentral

101.

Sun, T., Zhao, N., Zhao, X. L., Gu, Q., Zhang, S. W., Che, N., et al. (2010). Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry. Hepatology, 51(2), 545–556. https://doi.org/10.1002/hep.23311CrossRefPubMed

102.

Gong, W., Sun, B., Zhao, X., Zhang, D., Sun, J., Liu, T., et al. (2016). Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway. Oncotarget, 7(43), 70152–70167. https://doi.org/10.18632/oncotarget.12161CrossRefPubMedPubMedCentral

103.

Bao, S., Jin, S., Wang, C., Tu, P., Hu, K., & Lu, J. (2020). Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling. Journal of Cellular and Molecular Medicine, 24(23), 14110–14120. https://doi.org/10.1111/jcmm.16022CrossRefPubMedPubMedCentral

104.

Zan, S. J., Zhao, Y., Fang, T., & Chen, K. (2019). Expression of circular RNA hsa_circ_0014130 in lung adenocarcinoma cell lines and its effect on proliferation and invasion of lung adenocarcinoma cell line. Zhonghua Bing Li Xue Za Zhi, 48(12), 934–939. https://doi.org/10.3760/cma.j.issn.0529-5807.2019.12.004CrossRefPubMed

105.

Zhou, P., Xie, W., Huang, H. L., Huang, R. Q., Tian, C., Zhu, H. B., et al. (2020). circRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway. Aging (Albany NY), 12(13), 13338–13353. https://doi.org/10.18632/aging.103438CrossRef

106.

Zhai, Z., Fu, Q., Liu, C., Zhang, X., Jia, P., Xia, P., et al. (2019). Emerging roles of hsa-circ-0046600 targeting the miR-640/HIF-1α signalling pathway in the progression of HCC. Oncotargets and Therapy, 12, 9291–9302. https://doi.org/10.2147/ott.s229514CrossRefPubMedPubMedCentral

107.

Qian, W., Huang, T., & Feng, W. (2020). Circular RNA HIPK3 promotes EMT of cervical cancer through sponging miR-338-3p to up-regulate HIF-1α. Cancer Management and Research, 12, 177–187. https://doi.org/10.2147/cmar.s232235CrossRefPubMedPubMedCentral

108.

Shangguan, H., Feng, H., Lv, D., Wang, J., Tian, T., & Wang, X. (2020). Circular RNA circSLC25A16 contributes to the glycolysis of non-small-cell lung cancer through epigenetic modification. Cell Death & Disease, 11(6), 437. https://doi.org/10.1038/s41419-020-2635-5CrossRef

109.

Xu, G., Li, M., Wu, J., Qin, C., Tao, Y., & He, H. (2020). Circular RNA circNRIP1 sponges microRNA-138-5p to maintain hypoxia-induced resistance to 5-fluorouracil through hif-1α-dependent glucose metabolism in gastric carcinoma. Cancer Management and Research, 12, 2789–2802. https://doi.org/10.2147/cmar.s246272CrossRefPubMedPubMedCentral

110.

Peng, G., Meng, H., Pan, H., & Wang, W. (2021). CircRNA 001418 promoted cell growth and metastasis of bladder carcinoma via EphA2 by miR-1297. Current Molecular Pharmacology, 14(1), 68–78. https://doi.org/10.2174/1874467213666200505093815CrossRefPubMed

111.

Liu, L., Yang, X., Li, N. F., Lin, L., & Luo, H. (2019). Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma. Cell Cycle, 18(21), 2939–2953. https://doi.org/10.1080/15384101.2019.1664223CrossRefPubMedPubMedCentral

112.

Wu, D., Xia, A., Fan, T., & Li, G. (2021). circRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 sponge. Molecular Therapy - Nucleic Acids, 23, 13–26. https://doi.org/10.1016/j.omtn.2020.10.035CrossRefPubMed

113.

Guan, X., Zong, Z. H., Liu, Y., Chen, S., Wang, L. L., & Zhao, Y. (2019). circPUM1 promotes tumorigenesis and progression of ovarian cancer by sponging miR-615-5p and miR-6753-5p. Molecular Therapy - Nucleic Acids, 18, 882–892. https://doi.org/10.1016/j.omtn.2019.09.032CrossRefPubMedPubMedCentral

114.

He, J. H., Han, Z. P., Luo, J. G., Jiang, J. W., Zhou, J. B., Chen, W. M., et al. (2020). Hsa_Circ_0007843 Acts as a mIR-518c-5p sponge to regulate the migration and invasion of colon cancer SW480 Cells. Frontiers in Genetics, 11, 9. https://doi.org/10.3389/fgene.2020.00009CrossRefPubMedPubMedCentral

115.

Liu, H., Hu, G., Wang, Z., Liu, Q., Zhang, J., Chen, Y., et al. (2020). circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis. Theranostics, 10(23), 10791–10807. https://doi.org/10.7150/thno.47239CrossRefPubMedPubMedCentral

116.

Xiao, H., & Liu, M. (2020). Circular RNA hsa_circ_0053277 promotes the development of colorectal cancer by upregulating matrix metallopeptidase 14 via miR-2467-3p sequestration. Journal of Cellular Physiology, 235(3), 2881–2890. https://doi.org/10.1002/jcp.29193CrossRefPubMed

117.

Delgado-Bellido, D., Serrano-Saenz, S., Fernández-Cortés, M., & Oliver, F. J. (2017). Vasculogenic mimicry signaling revisited: Focus on non-vascular VE-cadherin. Molecular Cancer, 16(1), 65. https://doi.org/10.1186/s12943-017-0631-xCrossRefPubMedPubMedCentral

118.

Seftor, E. A., Meltzer, P. S., Schatteman, G. C., Gruman, L. M., Hess, A. R., Kirschmann, D. A., et al. (2002). Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: Role in vasculogenic mimicry. Critical Reviews in Oncology Hematology, 44(1), 17–27. https://doi.org/10.1016/s1040-8428(01)00199-8CrossRefPubMed

119.

Bartolomé, R. A., Torres, S., Isern de Val, S., Escudero-Paniagua, B., Calviño, E., Teixidó, J., et al. (2017). VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers. Oncotarget, 8(1), 215–227. https://doi.org/10.18632/oncotarget.13832CrossRefPubMed

120.

Hendrix, M. J., Seftor, E. A., Hess, A. R., & Seftor, R. E. (2003). Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma. Nature Reviews Cancer, 3(6), 411–421. https://doi.org/10.1038/nrc1092CrossRefPubMed

121.

Yang, J., Zhu, D. M., Zhou, X. G., Yin, N., Zhang, Y., Zhang, Z. X., et al. (2017). HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter. Oncotarget, 8(29), 47801–47815. https://doi.org/10.18632/oncotarget.17999CrossRefPubMedPubMedCentral

122.

McAllister, J. C., Zhan, Q., Weishaupt, C., Hsu, M. Y., & Murphy, G. F. (2010). The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts. Journal of Cutaneous Pathology, 37 Suppl 1(Suppl 1), 19–25. https://doi.org/10.1111/j.1600-0560.2010.01503.xCrossRefPubMed

123.

Topczewska, J. M., Postovit, L. M., Margaryan, N. V., Sam, A., Hess, A. R., Wheaton, W. W., et al. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: Role in melanoma aggressiveness. Nature Medicine, 12(8), 925–932. https://doi.org/10.1038/nm1448CrossRefPubMed

124.

Han, H., Du, L., Cao, Z., Zhang, B., & Zhou, Q. (2018). Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes. European Journal of Pharmacology, 818, 593–603. https://doi.org/10.1016/j.ejphar.2017.11.019CrossRefPubMed

125.

Cao, W., Xu, C., Li, X., & Yang, X. (2019). Twist1 promotes astrocytoma development by stimulating vasculogenic mimicry. Oncology Letters, 18(1), 846–855. https://doi.org/10.3892/ol.2019.10380CrossRefPubMedPubMedCentral

126.

Mao, X. G., Xue, X. Y., Wang, L., Zhang, X., Yan, M., Tu, Y. Y., et al. (2013). CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia. Neuro-Oncology, 15(7), 865–879. https://doi.org/10.1093/neuonc/not029CrossRefPubMedPubMedCentral

127.

Hess, A. R., Seftor, E. A., Gruman, L. M., Kinch, M. S., Seftor, R. E., & Hendrix, M. J. (2006). VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: Implications for vasculogenic mimicry. Cancer Biology & Therapy, 5(2), 228–233. https://doi.org/10.4161/cbt.5.2.2510CrossRef

128.

Paulis, Y. W., Soetekouw, P. M., Verheul, H. M., Tjan-Heijnen, V. C., & Griffioen, A. W. (2010). Signalling pathways in vasculogenic mimicry. Biochimica et Biophysica Acta, 1806(1), 18–28. https://doi.org/10.1016/j.bbcan.2010.01.001CrossRefPubMed

129.

Hendrix, M. J., Seftor, E. A., Meltzer, P. S., Gardner, L. M., Hess, A. R., Kirschmann, D. A., et al. (2001). Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry. Proceedings of the National Academy of Sciences of the United States of America, 98(14), 8018–8023. https://doi.org/10.1073/pnas.131209798CrossRefPubMedPubMedCentral

130.

Hess, A. R., Seftor, E. A., Gardner, L. M., Carles-Kinch, K., Schneider, G. B., Seftor, R. E., et al. (2001). Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: Role of epithelial cell kinase (Eck/EphA2). Cancer Research, 61(8), 3250–3255.PubMed

131.

Margaryan, N. V., Strizzi, L., Abbott, D. E., Seftor, E. A., Rao, M. S., Hendrix, M. J., et al. (2009). EphA2 as a promoter of melanoma tumorigenicity. Cancer Biology & Therapy, 8(3), 279–288. https://doi.org/10.4161/cbt.8.3.7485CrossRef

132.

Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014). FAK in cancer: Mechanistic findings and clinical applications. Nature Reviews Cancer, 14(9), 598–610. https://doi.org/10.1038/nrc3792CrossRefPubMedPubMedCentral

133.

Lu, X. S., Sun, W., Ge, C. Y., Zhang, W. Z., & Fan, Y. Z. (2013). Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. International Journal of Oncology, 42(6), 2103–2115. https://doi.org/10.3892/ijo.2013.1897CrossRefPubMed

134.

Zhang, J. T., Sun, W., Zhang, W. Z., Ge, C. Y., Liu, Z. Y., Zhao, Z. M., et al. (2014). Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway. BMC Cancer, 14, 193. https://doi.org/10.1186/1471-2407-14-193CrossRefPubMedPubMedCentral

135.

Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004). Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Biochemical and Biophysical Research Communications, 320(4), 1096–1102. https://doi.org/10.1016/j.bbrc.2004.06.054CrossRefPubMed

136.

Hess, A. R., & Hendrix, M. J. (2006). Focal adhesion kinase signaling and the aggressive melanoma phenotype. Cell Cycle, 5(5), 478–480. https://doi.org/10.4161/cc.5.5.2518CrossRefPubMed

137.

Fernandez-Cortes, M., Delgado-Bellido, D., & Oliver, F. J. (2019). Vasculogenic mimicry: Become an endothelial cell “but not so much.” Frontiers in Oncology, 9, 803. https://doi.org/10.3389/fonc.2019.00803CrossRefPubMedPubMedCentral

138.

Delgado-Bellido, D., Fernández-Cortés, M., Rodríguez, M. I., Serrano-Sáenz, S., Carracedo, A., Garcia-Diaz, A., et al. (2019). VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression. Cell Death and Differentiation, 26(2), 348–361. https://doi.org/10.1038/s41418-018-0125-4CrossRefPubMed

139.

Lissitzky, J. C., Parriaux, D., Ristorcelli, E., Vérine, A., Lombardo, D., & Verrando, P. (2009). Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro. Cancer Research, 69(3), 802–809. https://doi.org/10.1158/0008-5472.can-08-2391CrossRefPubMed

140.

Yousif, L. F., Di Russo, J., & Sorokin, L. (2013). Laminin isoforms in endothelial and perivascular basement membranes. Cell Adhesion & Migration, 7(1), 101–110. https://doi.org/10.4161/cam.22680CrossRef

141.

Seftor, R. E., Seftor, E. A., Koshikawa, N., Meltzer, P. S., Gardner, L. M., Bilban, M., et al. (2001). Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Research, 61(17), 6322–6327.PubMed

142.

Hess, A. R., Seftor, E. A., Seftor, R. E., & Hendrix, M. J. (2003). Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Research, 63(16), 4757–4762.PubMed

143.

Sood, A. K., Fletcher, M. S., Coffin, J. E., Yang, M., Seftor, E. A., Gruman, L. M., et al. (2004). Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. American Journal of Obstetrics and Gynecology, 190(4), 899–909. https://doi.org/10.1016/j.ajog.2004.02.011CrossRefPubMed

144.

Winkler, F. (2017). Hostile takeover: How tumours hijack pre-existing vascular environments to thrive. The Journal of Pathology, 242(3), 267–272. https://doi.org/10.1002/path.4904CrossRefPubMed

145.

Hirschi, K. K., Rohovsky, S. A., & D’Amore, P. A. (1998). PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. Journal of Cell Biology, 141(3), 805–814. https://doi.org/10.1083/jcb.141.3.805CrossRefPubMedPubMedCentral

146.

Yang, Z., Yao, H., Fei, F., Li, Y., Qu, J., Li, C., et al. (2018). Generation of erythroid cells from polyploid giant cancer cells: Re-thinking about tumor blood supply. Journal of Cancer Research and Clinical Oncology, 144(4), 617–627. https://doi.org/10.1007/s00432-018-2598-4CrossRefPubMed

147.

Liu, Q., Qiao, L., Liang, N., Xie, J., Zhang, J., Deng, G., et al. (2016). The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. Journal of Cellular and Molecular Medicine, 20(9), 1761–1769. https://doi.org/10.1111/jcmm.12851CrossRefPubMedPubMedCentral

148.

Wagenblast, E., Soto, M., Gutiérrez-Ángel, S., Hartl, C. A., Gable, A. L., Maceli, A. R., et al. (2015). A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature, 520(7547), 358–362. https://doi.org/10.1038/nature14403CrossRefPubMedPubMedCentral

149.

Lai, C. Y., Schwartz, B. E., & Hsu, M. Y. (2012). CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry. Cancer Research, 72(19), 5111–5118. https://doi.org/10.1158/0008-5472.can-12-0624CrossRefPubMedPubMedCentral

150.

Zhao, H., Chen, S., & Fu, Q. (2020). Exosomes from CD133(+) cells carrying circ-ABCC1 mediate cell stemness and metastasis in colorectal cancer. Journal of Cellular Biochemistry, 121(5–6), 3286–3297. https://doi.org/10.1002/jcb.29600CrossRefPubMed

151.

Chen, L., Zhou, H., & Guan, Z. (2019). CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/platelet-derived growth factor receptor B axis. Biochemical and Biophysical Research Communications, 512(4), 786–792. https://doi.org/10.1016/j.bbrc.2019.03.126CrossRefPubMed

152.

Xiang, T., Lin, Y. X., Ma, W., Zhang, H. J., Chen, K. M., He, G. P., et al. (2018). Vasculogenic mimicry formation in EBV-associated epithelial malignancies. Nature Communications, 9(1), 5009. https://doi.org/10.1038/s41467-018-07308-5CrossRefPubMedPubMedCentral

153.

Xu, S., Bai, J., Zhuan, Z., Li, B., Zhang, Z., Wu, X., et al. (2018). EBV-LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma. Oncology Reports, 40(1), 377–384. https://doi.org/10.3892/or.2018.6414CrossRefPubMed

154.

David, J. M., Dominguez, C., Hamilton, D. H., & Palena, C. (2016). The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance. Vaccines (Basel), 4(3), https://doi.org/10.3390/vaccines4030022

155.

Dwyer, J., Hebda, J. K., Le Guelte, A., Galan-Moya, E. M., Smith, S. S., Azzi, S., et al. (2012). Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS ONE, 7(9), e45562. https://doi.org/10.1371/journal.pone.0045562CrossRefPubMedPubMedCentral

156.

Logue, S. E., McGrath, E. P., Cleary, P., Greene, S., Mnich, K., Almanza, A., et al. (2018). Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nature Communications, 9(1), 3267. https://doi.org/10.1038/s41467-018-05763-8CrossRefPubMedPubMedCentral

157.

Mutalifu, N., Du, P., Zhang, J., Akbar, H., Yan, B., Alimu, S., et al. (2020). Circ_0000215 Increases the expression of CXCR2 and promoted the progression of glioma cells by sponging miR-495-3p. Technology in Cancer Research & Treatment, 19, 1533033820957026. https://doi.org/10.1177/1533033820957026CrossRef

158.

Seaman, S., Zhu, Z., Saha, S., Zhang, X. M., Yang, M. Y., Hilton, M. B., et al. (2017). Eradication of tumors through simultaneous ablation of CD276/B7-H3-positive tumor cells and tumor vasculature. Cancer Cell, 31(4), 501-515.e508. https://doi.org/10.1016/j.ccell.2017.03.005CrossRefPubMedPubMedCentral

159.

Wang, L., Zhang, G. C., Kang, F. B., Zhang, L., & Zhang, Y. Z. (2019). hsa_circ0021347 as a potential target regulated by B7–H3 in modulating the malignant characteristics of osteosarcoma. BioMed Research International, 2019, 9301989. https://doi.org/10.1155/2019/9301989CrossRefPubMedPubMedCentral

160.

Zeng, Y., Yao, X., Liu, X., He, X., Li, L., Liu, X., et al. (2019). Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. The Journal of Extracellular Vesicles, 8(1), 1629865. https://doi.org/10.1080/20013078.2019.1629865CrossRefPubMed

161.

Huang, X. Y., Huang, Z. L., Huang, J., Xu, B., Huang, X. Y., Xu, Y. H., et al. (2020). Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. Journal of Experimental & Clinical Cancer Research, 39(1), 20. https://doi.org/10.1186/s13046-020-1529-9CrossRef

162.

Rezaei, M., Martins Cavaco, A. C., Stehling, M., Nottebaum, A., Brockhaus, K., Caliandro, M. F., et al. (2020). Extracellular vesicle transfer from endothelial cells drives VE-cadherin expression in breast cancer cells, thereby causing heterotypic cell contacts. Cancers (Basel), 12(8), https://doi.org/10.3390/cancers12082138

163.

Bergers, G., & Fendt, S. M. (2021). The metabolism of cancer cells during metastasis. Nature Reviews Cancer, 21(3), 162–180. https://doi.org/10.1038/s41568-020-00320-2CrossRefPubMedPubMedCentral

164.

Zhang, H., & Lu, B. (2020). The roles of ceRNAs-mediated autophagy in cancer chemoresistance and metastasis. Cancers (Basel), 12(10), https://doi.org/10.3390/cancers12102926

165.

Zang, J., Lu, D., & Xu, A. (2020). The interaction of circRNAs and RNA binding proteins: An important part of circRNA maintenance and function. Journal of Neuroscience Research, 98(1), 87–97. https://doi.org/10.1002/jnr.24356CrossRefPubMed

166.

Shang, Q., Yang, Z., Jia, R., & Ge, S. (2019). The novel roles of circRNAs in human cancer. Molecular Cancer, 18(1), 6. https://doi.org/10.1186/s12943-018-0934-6CrossRefPubMedPubMedCentral

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers

Abstract

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Adipocytokines and disease progression in endometrial cancer: a systematic review

Anti-HER2 therapy in metastatic breast cancer: many choices and future directions

Glioma: molecular signature and crossroads with tumor microenvironment

Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology

Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective

Glycosylation as a regulator of site-specific metastasis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer